Thomas P. Loughran

基本信息

Career Trajectory

Bio

His career as a physician scientist is a testament to translational research beginning with his discovery of large granular lymphocyte (LGL) leukemia. He has published numerous articles in high impact peer-reviewed journals including The New England Journal of Medicine, Annals of Internal Medicine, Lancet, Journal of Clinical Investigation, Journal of Clinical Oncology, and Blood. He and his wife, Kenna, have two daughters, Kathleen and Kelly.

Research Interests

Papers共 306 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

A Phase I Study Using Bortezomib (velcade), Cladribine, and Rituximab in Treating Patients over 50 Years Old with Mantle Cell Lymphoma

Jeffrey J. Pu, Kristin N. Berger,Chunlei Zheng,Nhan Do,David F. Claxton,W. Christopher Ehmann,Joseph J. Drabick,Haiquan Li,Thomas P. Loughran Jr,Elliot M. Epner

FRONTIERS IN ONCOLOGY (2024)

Cited0Views0WOSBibtex

Activating STAT3 Mutations in CD8+ T-cells Correlate to Serological Positivity in Rheumatoid Arthritis

Katharine Moosic,Thomas Olson, Mark Freijat,Samara Khalique,Cait Hamele,Bryna Shemo, Jesse Boodoo, William Baker, Gitanjali Khurana, Matthew Schmachtenberg, Tristin Duffy,Aakrosh Ratan,Erika Darrah,Felipe Andrade,Marieke Jones,Kristine Olson,David Feith,Thomas Loughran,Donald Kimpel

ARTHRITIS & RHEUMATOLOGY (2024): 106-108

Cited0Views0WOSBibtex

Mitochondria Inside Acute Myeloid Leukemia Cells Hydrolyze ATP to Resist Chemotherapy

James T Hagen,Mclane M Montgomery,Raphael T Aruleba, Brett R Chrest,Thomas D Green,Miki Kassai,Tonya N Zeczycki,Cameron A Schmidt,Debajit Bhowmick,Su-Fern Tan,David J Feith,Charles E Chalfant,Thomas P Loughran,Darla Liles,Mark D Minden,Aaron D Schimmer,Myles C Cabot,Joseph M Mclung,Kelsey H Fisher-Wellman

bioRxiv the preprint server for biology (2024)

Cited0Views0WOSBibtex

Uncovering the Molecular Basis for Clinically Relevant Sphingolipidomic Subtypes in Acute Myeloid Leukemia

B. Bishal Paudel,Su-Fern Tan,Johnson Ung,David Claxton,David J. Feith,Thomas P. Loughran,Kevin A. Janes

CANCER RESEARCHno. 6 (2024)

Cited0Views0Bibtex

Plurality over Parsimony: when Two Diagnoses Are More Likely Than One

Jasraj S. Raghuwanshi, Nathan Roberts,Thomas P. Loughran Jr.,Firas El Chaer, Mark Girton,Glenn Moulder

Journal of General Internal Medicine (2024)

Cited0Views0WOSBibtex

Preclinical Development of a Romidepsin Nanoparticle Demonstrates Superior Tolerability and Efficacy in Models of Human T-Cell Lymphoma and Large Granular Lymphocyte Leukemia

Ipsita Pal,Anuradha Illendula,Andrea Joyner,John Sanil Manavalan, Tess M Deddens, Ariana Sabzevari, Deepthi P Damera, Samir Zuberi,Enrica Marchi,Todd E Fox,Marya E Dunlap-Brown,Kallesh D Jayappa,Jeffrey W Craig,Thomas P Loughran,David J Feith,Owen A O'Connor

biorxiv（2024）

Cited0Views0WOSBibtex

Preclinical Development of a Novel Romidepsin Nanoparticle for the Treatment of TCell Lymphoid Malignancies

Ipsita Pal,Anuradha Illendula,Andrea Joyner, Tess M. Deddens, Deepthi P. Damera,Todd E. Fox,Marya E. Dunlap-Brown,Kallesh D. Jayappa,Thomas P. Loughran,David J. Feith,Owen A. O'Connor

CANCER RESEARCHno. 6 (2024)

Cited0Views0Bibtex

Supplementary Data 1 from KLRG1 Cell Depletion As a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes

Bimarzhan Assatova,Robert Willim,Christopher Trevisani, Garrett Haskett, Khyati Maulik Kariya, Kusha Chopra,Sung Rye Park,Michael Yevgeniy Tolstorukov, Sean M. McCabe,Jessica Duffy,Abner Louissaint,Jani Huuhtanen,Dipabarna Bhattacharya,Satu Mustjoki,Min Jung Koh,Foster Powers,Elizabeth A. Morgan,Lei Yang,Brandy Pinckney,Matthew J. Cotton,Andrew Crabbe,Jessica Beth Ziemba,Ian Brain,Tayla B. Heavican-Foral,Javeed Iqbal, Ronald Nemec, Anna Baird Rider, Josie Germain Ford,Min Ji Koh, Nora Scanlan,David J. Feith,Thomas P. Loughran,Won Seog Kim,Jaehyuk Choi,Juliette Roels,Lena Boehme,Tom Putteman,Tom Taghon,Jeffrey A. Barnes,P. Connor Johnson,Eric D. Jacobsen,Steven A. Greenberg,David M. Weinstock,Salvia Jain

crossref（2024）

Cited0Views0Bibtex

Abstract CT145: the Final Results of a Phase I Study Using Velcade (bortezomib), Cladribine, and Rituximab (VCR) in Treating Elderly Patient with Mantle Cell Lymphoma

Jeffrey J. Pu,Kristin Berger,David F. Claxton,Joseph J. Drabick,Thomas P. Loughran,Elliot Epner

Cancer Researchno. 7_Supplement (2024): CT145-CT145

Cited0Views0Bibtex

Acid Ceramidase Inhibition Enhances Venetoclax Sensitivity in Preclinical Models of Acute Myeloid Leukemia

Johnson Ung,Su-Fern Tan,Jeremy J. Shaw,Todd E. Fox, Maansi Taori,David F. Claxton,Kelsey H. Fisher-Wellman,Myles C. Cabot,David J. Feith,Thomas P. Loughran

CANCER RESEARCH（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 306 篇Author StatisticsCo-AuthorSimilar Experts